MedTrace Logo

SinuSurf vs. Saline Solution in Normal Subjects

NCT02728505 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-03-14

No results posted yet for this study

Summary

Single-center, prospective, placebo controlled trial of tolerability and safety of low-concentration SinuSurf sinus irrigation solution in normal subjects. Forty (40) healthy subjects aged 18-65 will be enrolled in the study.

Conditions

  • Rhinosinusitis

Interventions

DRUG

SinuSurf irrigation twice daily

DRUG

NeilMed Sinus rinse irrigation twice daily

Sponsors & Collaborators

  • NeilMed Pharmaceuticals

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Justin Turner, MD, PhD · Vanderbilt University Medical Center

  • Rakesh K. Chandra, MD · Vanderbilt University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-12
Primary Completion
2017-01-20
Completion
2017-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02728505 on ClinicalTrials.gov